Patents by Inventor Howard Prentice

Howard Prentice has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260027234
    Abstract: The present disclosure provides recombinant vectors encoding a choline acetyltransferase (ChAT) polypeptide, compositions thereof, and methods of use thereof.
    Type: Application
    Filed: July 24, 2025
    Publication date: January 29, 2026
    Inventors: Jang-Yen Wu, Howard Prentice, Subash Bhandari
  • Publication number: 20080305083
    Abstract: Compositions and methods for reducing neovascularization. Purified nucleic acid constructs and vectors encoding an anti-angiogenic protein operably linked to a GFAP promoter. Vectors can include at least one hypoxia regulated element, enhancer element and silencer element. Gene therapy methods for reducing, delaying or preventing neovascularization based on the nucleic acid constructs and vectors.
    Type: Application
    Filed: April 17, 2008
    Publication date: December 11, 2008
    Applicant: FLORIDA ATLANTIC UNIVERSITY
    Inventors: C. Kathleen DOREY, Janet C. BLANKS, Howard PRENTICE
  • Publication number: 20050261234
    Abstract: Compositions and methods for reducing neovascularization. Purified nucleic acid constructs and vectors encoding an anti-angiogenic protein operably linked to a GFAP promoter. Vectors can include at least one hypoxia regulated element, enhancer element and silencer element. Gene therapy methods for reducing, delaying or preventing neovascularization based on the nucleic acid constructs and vectors.
    Type: Application
    Filed: April 22, 2005
    Publication date: November 24, 2005
    Applicant: Florida Atlantic University
    Inventors: C. Dorey, Janet Blanks, Howard Prentice